Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma.

Journal of clinical and experimental hematopathology : JCEH

Volumn 48, Issue 1, 2008, Pages 25-28

  Shimada, Kazuyuki ^a   Kosugi, Hiroshi ^a   Narimatsu, Hiroto ^a   Shimada, Satoko ^a   Suzuki, Tatsuya ^a   Ito, Masafumi ^a   Kinoshita, Tomohiro ^a   Mori, Naoyoshi ^a   Naoe, Tomoki ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; LARGE CELL LYMPHOMA; PATHOPHYSIOLOGY; REMISSION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 49649091562     PISSN: 13464280     EISSN: None     Source Type: Journal    
DOI: 10.3960/jslrt.48.25     Document Type: Article

References (0)